Fig. 1From: Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)Classification tree of G-CSF, FN onset, and FN rate in cycle 1. FN incidence is shown as a percentage of the patients receiving each treatment. BMI body mass index, FN febrile neutropenia, G-CSF granulocyte colony-stimulating factorBack to article page